Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Rajakumar, A, Cerdeira, AS, Rana, S, Zsengeller, Z, Edmunds, L, Jeyabalan, A, Hubel, CA, Stillman, IE, Parikh, SM, Karumanchi, SA
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	American Heart Association 2012

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
de réir: Zsuzsanna K. Zsengellér, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: first in vivo evidence
de réir: Cerdeira, AS, et al.
Foilsithe / Cruthaithe: (2019)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
de réir: Vincent Dupont, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
de réir: Lissette C. Sánchez-Aranguren, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Predictive accuracy of soluble FMS-like tyrosine kinase-1/placental growth factor ratio for preeclampsia in Japan: a systematic review
de réir: Yamazaki, T, et al.
Foilsithe / Cruthaithe: (2020)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
de réir: Vorapong Phupong, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Antiangiogenic Biomarker Soluble Fms-like Tyrosine Kinase-1 in Pregnancy Complicated with Preeclampsia: A Cohort Study
de réir: Mandeep Kaur, et al.
Foilsithe / Cruthaithe: (2021-12-01)

One step closer to a cure for preeclampsia? Boosting the natural affinity of VEGF (vascular endothelial growth factor) to sFlt (soluble fms-like tyrosine kinase)-1
de réir: Cerdeira, AS, et al.
Foilsithe / Cruthaithe: (2020)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
de réir: Carmen Rădulescu, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: The SaPPPhirE Study.
de réir: Agrawal, S, et al.
Foilsithe / Cruthaithe: (2017)

Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
de réir: Zeisler, H, et al.
Foilsithe / Cruthaithe: (2016)

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
de réir: Cerdeira, AS, et al.
Foilsithe / Cruthaithe: (2021)

The ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial
de réir: Palma Dos Reis, CR, et al.
Foilsithe / Cruthaithe: (2024)

Is prolonging gestation in preeclampsia for better or worse in preventing cardiovascular disease?
de réir: Cerdeira, AS, et al.
Foilsithe / Cruthaithe: (2021)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
de réir: Kifle, MM, et al.
Foilsithe / Cruthaithe: (2022)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
de réir: Natalie J. Hannan, et al.
Foilsithe / Cruthaithe: (2017-05-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
de réir: Meron M. Kifle, et al.
Foilsithe / Cruthaithe: (2022-06-01)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
de réir: Mahmoud Fathy Hassan, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
de réir: Roxanne Hastie, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy
de réir: Ria Andina, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
de réir: Verlohren, S, et al.
Foilsithe / Cruthaithe: (2008)

Calcitonin gene-related peptide protects from soluble fms-like tyrosine kinase-1-induced vascular dysfunction in a preeclampsia mouse model
de réir: Akansha Mishra, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
de réir: Park So-Yeon, et al.
Foilsithe / Cruthaithe: (2008-07-01)

The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
de réir: Lai C, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
de réir: Alaa Raeed, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Pengaruh Likopen terhadap Kadar Soluble FMS-Like Tyrosine Kinase 1 pada Preeklamsi
de réir: Vaulinne Basyir, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Cereral Circulation in Preeclampsia
de réir: A. A. Ivshin, et al.
Foilsithe / Cruthaithe: (2008-02-01)

The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience
de réir: Andrijana Müller, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
de réir: John Wantania, et al.
Foilsithe / Cruthaithe: (2013-08-01)

Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
de réir: Melissa I March, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Translation of mechanistic advances in preeclampsia to the clinic: long and winding road
de réir: Thadhani, R, et al.
Foilsithe / Cruthaithe: (2024)

Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
de réir: Hadfield Ruth, et al.
Foilsithe / Cruthaithe: (2011-06-01)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
de réir: Jinsong Gao, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
de réir: Xinwen Chang, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy
de réir: Muhammad Ilham Aldika Akbar, et al.
Foilsithe / Cruthaithe: (2018-10-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
de réir: Nesreen Nasser, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Circulating microparticles and immunomodulation in pregnancy and preeclampsia
de réir: Redman, C, et al.
Foilsithe / Cruthaithe: (2007)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
de réir: Jiawu Zhao, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
de réir: Evelyn A. Huhn, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Prevalence of human respiratory syncytial virus circulating in Iran
de réir: Vahid Salimi, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Míreanna comhchosúla

Míreanna comhchosúla